Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays

被引：69

作者：

Fung, Becky ^{[1
]}

Gopez, Allan ^{[1
,2
]}

Servellita, Venice ^{[1
,2
]}

Arevalo, Shaun ^{[1
,2
]}

Ho, Coral ^{[1
]}

Deucher, Anne ^{[1
]}

Thornborrow, Ed ^{[1
]}

Chiu, Charles ^{[1
,2
]}

Miller, Steve ^{[1
,2
]}

机构：

[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA

[2] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2020年 / 58卷 / 09期

关键词：

SARS-CoV-2; limit of detection;

D O I：

10.1128/JCM.01535-20

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Analytical sensitivity for SARS-CoV-2 detection is a key performance metric for the evaluation of viral detection assays. We determined analytical limits of detection for seven SARS-CoV-2 assays using serial dilutions of pooled patient material quantified with droplet digital PCR. Limits of detection ranged from <= 10 to 74 copies/ml for commercial high-throughput laboratory analyzers (Roche Cobas, Abbott m2000, and Hologic Panther Fusion) and 167 to 511 copies/ml for sample-toanswer (DiaSorin Simplexa, GenMark ePlex) and point-of-care instruments (Abbott ID NOW). The CDC assay yielded limits of detection ranging from 85 to 499 copies/ml, depending on the extraction method and thermocycler used. These results can help to inform the assay choice for testing approaches to manage the current COVID-19 outbreak.

引用

页数：4

共 11 条

[1] [Anonymous], 2022, J CLIN MICROBIOL, DOI DOI 10.1128/JCM.02919-20
[2] [Anonymous], 2020, ABBOTT ID NOW COVID
[3] Validation of Laboratory-Developed Molecular Assays for Infectious Diseases
Burd, Eileen M.
[J]. CLINICAL MICROBIOLOGY REVIEWS, 2010, 23 (03) : 550 - +
[4] Comparison of Two High-Throughput Reverse Transcription-PCR Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2
Craney, Arryn R.
Velu, Priya D.
Satlin, Michael J.
Fauntleroy, Kathy A.
Callan, Katrina
Robertson, Amy
La Spina, Marisa
Lei, Beryl
Chen, Anqi
Alston, Tricia
Rozman, Anna
Loda, Massimo
Rennert, Hanna
Cushing, Melissa
Westblade, Lars F.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
[5] Furukawa Nathan W, 2020, Emerg Infect Dis, V26, DOI 10.3201/eid2607.201595
[6] Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
Harrington, Amanda
Cox, Brian
Snowdon, Jennifer
Bakst, Jonathan
Ley, Erin
Grajales, Patricia
Maggiore, Jack
Kahn, Stephen
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
[7] Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
La Scola, Bernard
Le Bideau, Marion
Andreani, Julien
Hoang, Van Thuan
Grimaldier, Clio
Colson, Philippe
Gautret, Philippe
Raoult, Didier
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (06) : 1059 - 1061
[8] Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories
Lieberman, Joshua A.
Pepper, Gregory
Naccache, Samia N.
Huang, Meei-Li
Jerome, Keith R.
Greninger, Alexander L.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
[9] ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens
Suo, Tao
Liu, Xinjin
Feng, Jiangpeng
Guo, Ming
Hu, Wenjia
Guo, Dong
Ullah, Hafiz
Yang, Yang
Zhang, Qiuhan
Wang, Xin
Sajid, Muhanmmad
Huang, Zhixiang
Deng, Liping
Chen, Tielong
Liu, Fang
Xu, Ke
Liu, Yuan
Zhang, Qi
Liu, Yingle
Xiong, Yong
Chen, Guozhong
Lan, Ke
Chen, Yu
[J]. EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 1259 - 1268
[10] Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens
Zhen, Wei
Manji, Ryhana
Smith, Elizabeth
Berry, Gregory J.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)

← 1 2 →